Mevacor-to-Lescol Switches Should Encourage Lescol 40 mg - Study
Executive Summary
Programs to substitute Novartis' Lescol (fluvastatin) for Merck's Mevacor (lovastatin) should consider using only the 40 mg dose of Lescol to avoid a significant worsening of outcomes, a study of one switch program concluded.
You may also be interested in...
APhA depression management study
American Pharmacists Association is launching a depression-management program to evaluate the effect of pharmacist-delivered medication therapy management-type services. Project ImPACT: Depression (Improving Persistence And Compliance with Therapy) will focus on whether pharmacists can improve depression treatent adherence. Project ImPACT has previously targeted hyperlipidemia and osteoporosis (1"The Pink Sheet" March 30, 1998, p. 20). Support for the depression study is provided by Wyeth, manufacturer of the serotonin/norepinephrine reuptake inhibitor Effexor XR (venlafaxine extended-release)...
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011